PubRank

M Jourdan

Author PubWeight™ 56.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 1989 2.78
2 Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 1994 2.10
3 Prioritising waiting lists. Health Trends 1990 1.78
4 Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells. Blood 1990 1.75
5 Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 1991 1.73
6 Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J Clin Invest 1989 1.72
7 JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells. Br J Haematol 2000 1.45
8 Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. Eur Cytokine Netw 1991 1.42
9 Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors. Leukemia 2000 1.35
10 Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays. Blood 2001 1.34
11 Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma. Oncogene 2006 1.21
12 Thin film growth of Fe-based superconductors: from fundamental properties to functional devices. A comparative review. Rep Prog Phys 2014 1.21
13 Complete nucleotide sequence of the cloned infectious genome of Junonia coenia densovirus reveals an organization unique among parvoviruses. Virology 1992 1.19
14 Mutations of the p53 gene in human myeloma cell lines. Oncogene 1992 1.13
15 Dukes A carcinoma after colonic interposition for oesophageal stricture. Gut 1989 1.06
16 Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice. J Exp Med 1996 1.06
17 Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation. Leukemia 2010 1.03
18 IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis. J Immunol 1998 1.01
19 The role of interleukin 1 and interleukin 2 in human T colony formation. Cell Immunol 1983 0.97
20 Effects of amino acid phi,psi propensities and secondary structure interactions in modulating H alpha chemical shifts in peptide and protein beta-sheet. J Am Chem Soc 2001 0.96
21 The expression of Fc receptors for immunoglobulin G in human rectal epithelium. AIDS 1991 0.95
22 Cytokine gene expression in human multiple myeloma. Br J Haematol 1993 0.94
23 Activation molecules on human myeloma cells. Curr Top Microbiol Immunol 1999 0.87
24 Interleukin-10 and Gp130 cytokines in human multiple myeloma. Leuk Lymphoma 1999 0.87
25 Colocutaneous fistula as late complication of total hip replacement in rheumatoid arthritis. J R Soc Med 1985 0.87
26 Hyaluronic acid induces survival and proliferation of human myeloma cells through an interleukin-6-mediated pathway involving the phosphorylation of retinoblastoma protein. J Biol Chem 2001 0.86
27 Restriction maps and sequence homologies of two densovirus genomes. J Gen Virol 1990 0.86
28 Phenotypic analysis of human myeloma cell lines. Blood 1989 0.86
29 Production of growth factors by human myeloma cells. Cancer Res 1987 0.84
30 Behavioral fever and therapy in a rickettsia-infected Orthoptera. Am J Physiol 1986 0.84
31 Induction of human T colony formation by phorbol myristate acetate. Scand J Immunol 1983 0.83
32 Investigation of the complement receptor 3 (CD11b/CD18) in human rectal epithelium. Clin Exp Immunol 1995 0.83
33 Production of interleukin 2 in multiple myeloma. Clin Exp Immunol 1986 0.82
34 Abasic site recognition in DNA as a new strategy to potentiate the action of anticancer alkylating drugs? J Med Chem 1999 0.82
35 Sulphate, acid-base, and mineral balances of obese women during weight loss. Am J Clin Nutr 1980 0.81
36 Epitope analysis of human IL-6 receptor gp80 molecule with monoclonal antibodies. Eur Cytokine Netw 1994 0.81
37 Up-regulation of interleukin (IL)-6 receptor gene expression in vitro and in vivo in IL-6 deprived myeloma cells. FEBS Lett 1992 0.81
38 Efficient transduction of healthy and malignant plasma cells by lentiviral vectors pseudotyped with measles virus glycoproteins. Leukemia 2012 0.80
39 Protein-sparing effect in obese women fed low calorie diets. Am J Clin Nutr 1974 0.79
40 Colonoscopy: a survey of its value in a teaching hospital surgical unit. J R Soc Med 1981 0.79
41 Febrile ulceronecrotic Mucha-Habermann disease: treatment with infliximab and intravenous immunoglobulins and review of the literature. Dermatology 2013 0.79
42 Interleukin-6 is a major myeloma cell growth factor in vitro and in vivo especially in patients with terminal disease. Curr Top Microbiol Immunol 1990 0.79
43 Production of B-cell growth factor interleukin 2 and gamma interferon by peripheral blood lymphocytes from patients with chronic lymphocytic leukemia of B-cell type. Am J Hematol 1988 0.78
44 The defect in peripheral blood B-cell activation in patients with multiple myeloma is not due to a deficiency in the production of B-cell growth and differentiation factors. J Clin Immunol 1989 0.78
45 Spontaneous secretion of tumor necrosis factor-beta by human myeloma cell lines. Cancer 1989 0.78
46 Interleukin 2 production in B cell chronic lymphocytic leukemia. Blood 1985 0.78
47 Experimental and theoretical studies of the conformational perturbations induced by an abasic site. J Biomol Struct Dyn 1999 0.78
48 The use of prophylactic subcutaneous heparin in patients undergoing hernia repairs. Br J Clin Pract 1984 0.77
49 The turnover rate of serum glycerides in the lipoproteins of fasting obese women during weight loss. Am J Clin Nutr 1974 0.77
50 Risk factors for avian influenza and Newcastle disease in smallholder farming systems, Madagascar highlands. Prev Vet Med 2011 0.77
51 Kaposi's sarcoma-associated herpesvirus is not detected with immunosuppression in multiple myeloma. Blood 1998 0.76
52 Therapeutic aspiration of pseudocysts: a cautionary tale of the pancreas. Am J Gastroenterol 1986 0.76
53 Control of human T-colony formation by interleukin-2. Immunology 1985 0.75
54 The role of interleukin-2 in T colony formation by human pre-T cells (pTCFC). Clin Exp Immunol 1984 0.75
55 Modulation of PHA-induced T colony formation by phorbol myristic acetate. Clin Exp Immunol 1983 0.75
56 [Pierre-Marie-Bamberger syndrome and hydro-aeric lesion]. Rev Pneumol Clin 1994 0.75
57 [Pleurisy complicating pseudomembranous colitis]. Presse Med 1993 0.75
58 Interleukin 6 production by cardiac myxomas may explain constitutional symptoms. J Thorac Cardiovasc Surg 1992 0.75
59 Templating peptide folding on the surface of a micelle: nucleating the formation of a beta-hairpin. Bioorg Med Chem Lett 2000 0.75
60 Energy expenditure of obese women during weight loss. Am J Clin Nutr 1972 0.75
61 Interleukin 2 production in bone marrow of normal individuals and patients associated with B-cell chronic lymphocytic leukaemia. Br J Haematol 1988 0.75
62 Differential effects of diet composition and weight loss on glucose tolerance in obese women. Am J Clin Nutr 1974 0.75
63 [An attempt at identification of osteoclastic activation factors implicated in myeloma]. Rev Rhum Mal Osteoartic 1988 0.75
64 [European training]. Rev Infirm 1992 0.75
65 Bleeding oesophageal varices: a scheme of management. Br J Clin Pract 1983 0.75
66 "Haemangioma": an endoscopic artefact. Short report. Endoscopy 1984 0.75
67 Diathermy and cautery equipment. Br J Hosp Med 1981 0.75
68 False-positive diagnosis of adrenal phaeochromocytoma on metaiodobenzylguanidine (MIBG) [correction of MIGB] scan. Br J Clin Pract 1990 0.75
69 Human natural killer cells suppress the proliferation of B cells. Immunol Lett 1990 0.75
70 [Parotid metastasis disclosing bronchial carcinoma]. Rev Pneumol Clin 1993 0.75